dimethyldioctadecylammonium has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baechtel, FS; Prager, MD | 1 |
| Farmer, JL; Kanar, MC; Prager, MD; Vanderzee, J | 1 |
2 other study(ies) available for dimethyldioctadecylammonium and Leukemia L 1210
| Article | Year |
|---|---|
Interaction of antigens with dimethyldioctadecylammonium bromide, a chemically defined biological response modifier.
Topics: Adjuvants, Immunologic; Animals; Antigens; Erythrocytes; Kinetics; Leukemia L1210; Mice; Mice, Inbred DBA; Quaternary Ammonium Compounds; Sheep; Sialic Acids | 1982 |
Effect of dimethyldioctadecylammonium bromide induced macrophages on malignant cell proliferation.
Topics: Adjuvants, Immunologic; Animals; Cell Division; Cytotoxicity, Immunologic; Humans; Leukemia L1210; Lipopolysaccharides; Macrophages; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasms; Quaternary Ammonium Compounds | 1985 |